Posard Matthew L.

CIK 00015437926 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001543792

Recent Transactions

50 trades

Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2025-06-23+45,000→ 45,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-05-01+5,750→ 5,750 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-05-01+4,165→ 74,039 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-14$57.70/sh−9,881→ 69,874 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-13$56.19/sh−10,000→ 79,755 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-12$55.72/sh−10,000→ 89,755 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2024-06-14+45,000→ 45,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-12$50.62/sh−10,000→ 99,755 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-11$50.01/sh−10,000→ 109,755 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-04-25+6,501→ 119,755 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-04-25+8,804→ 8,804 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2023-06-15+45,000→ 45,000 total
Award
Talis Biomedical Corp$TLIS
Stock option (right to buy)
2023-06-09+95,000→ 95,000 total
Award
DermTech, Inc.
Common Stock
2023-06-01+35,714→ 158,215 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2023-05-05+11,371→ 11,371 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-05-05+8,065→ 113,254 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2022-12-06$56.12/sh−10,000→ 105,189 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2022-12-05$55.74/sh−10,000→ 115,189 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2022-12-02$58.80/sh−10,000→ 125,189 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2022-06-15+86,467→ 86,467 total
Award
Talis Biomedical Corp$TLIS
Stock Option (right to buy)
2022-06-10+95,000→ 95,000 total
Award
DermTech, Inc.
Common Stock
2022-05-26+26,480→ 122,501 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2022-05-05+6,206→ 135,189 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2021-12-01$4.46/sh+10,000→ 40,000 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2021-12-01$4.50/sh+10,000→ 30,000 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2021-12-01$4.45/sh+10,000→ 50,000 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2021-11-30$4.57/sh+20,000→ 20,000 total
Award
DermTech, Inc.
Common Stock
2021-05-26+4,497→ 91,360 total
Award
DermTech, Inc.
Common Stock
2021-05-26+4,661→ 96,021 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2021-05-05+5,230→ 128,983 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17$16.00/sh+62,500→ 62,500 total
Purchase
DermTech, Inc.
Common Stock
2021-01-11$29.50/sh+33,898→ 86,863 total
Award
DermTech, Inc.
Common Stock
2020-06-17+8,000→ 52,965 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock
2020-04-30+8,829→ 123,753 total
Exercise/Conversion
DermTech, Inc.
Common Stock
2020-04-29$6.94/sh+9,702→ 44,965 total
Exercise/Conversion
DermTech, Inc.
Stock Option (right to buy)
2020-04-29−9,702→ 0 total
Award
DermTech, Inc.
Common Stock
2020-01-30+6,000→ 35,263 total
Exercise/Conversion
DermTech, Inc.
Restricted Stock Units
2019-12-31−15,994→ 0 total
Exercise/Conversion
DermTech, Inc.
Common Stock
2019-12-31+15,994→ 29,263 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-05-02+12,173→ 114,924 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-05-02+10,363→ 102,751 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2017-05-04+14,135→ 92,388 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2016-05-04+20,202→ 78,253 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2016-01-04+150,000→ 650,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2015-05-06+13,175→ 58,051 total
Exercise/Conversion
ILLUMINA, INC.$ILMN
Non-Qualified Stock Option (right to buy)
2013-05-30−2,836→ 7,563 total
Sale
ILLUMINA, INC.$ILMN
Common Stock
2013-05-30$70.80/sh−2,836→ 30,858 total
Exercise/Conversion
ILLUMINA, INC.$ILMN
Common Stock
2013-05-30$37.04/sh+2,836→ 33,694 total
Sale
ILLUMINA, INC.$ILMN
Common Stock
2013-04-11$57.95/sh−2,100→ 30,858 total
Exercise/Conversion
ILLUMINA, INC.$ILMN
Non-Qualified Stock Option (right to buy)
2013-04-11−5,032→ 0 total

Companies

Recent Filings

Address

5200 ILLUMINA WAY

SAN DIEGO, CA, 92122

View on SEC.gov